That is misleading commentary. You don't create revenue by over...

First 35 Last

Share
Profile

Follow
roscoeb

304 Posts.

26/12/16

11:43

Post #: 21558236
Share

Originally posted by RandomK ↑

Meh most of your points I agree with. Pretty much the scenario is that if bal can get positive eps growth/ revenue growth in fy18/19 then the stock should slowly recover. This recovery story will be driven by future demand and the incompetence of management - the point that people seem to be missing - the thing that most retail investors underplay and a decent reason instos outperform them. Who was Laura before Bellamys? Just an accountant at KPMG LOL. Few years later she is managing a $1bn company with reluctance to show transparency and other things I can't discuss due to confidentiality.

Anyways plug in the numbers into a DCF and you will get a $4-$6 target if you assume 0% future growth past fy17 - this is what most analysts are currently doing fyi. At this point, it's hard to argue with them given A2s /aptamils complete dominance in the market and bals losing market share + inventory mistakes.

Also anyone who didn't know, this whole fiasco mainly occurred due to the bal management front ending fy16 revenues by over ordering from suppliers to get a better figure for fy16. This is the sign of an incompetent and inexperienced management that will do what it takes to get their STIs met. This led to the excess inventory in fy17 which meant lower prices and finally the daigou trade getting cut out.

Expand

That is misleading commentary.
You don't create revenue by over ordering from suppliers. You recognise revenue when you sell product, not when you buy it.
Auditors make sure that is normal practice so stop running false and misleading commentary from you. Get your story straight.

BAL Price at posting: $6.68 Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

TNC

True North increases silver metal at QLD's Vero deposit by 20%

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Emerald & Azure score Digger & Dealer awards

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

There are more pages in this discussion • 492 more messages in this thread...

First 35 Last

Add BAL (ASX) to my watchlist

That is misleading commentary. You don't create revenue by over...

Top Stories

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Revolutionary inverter technology leads the clean energy charge

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

True North increases silver metal at QLD's Vero deposit by 20%

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Emerald & Azure score Digger & Dealer awards

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Featured News